Firering Strategic Minerals: From explorer to producer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksImmupharma Share News (IMM)

Share Price Information for Immupharma (IMM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2.24
Bid: 2.18
Ask: 2.30
Change: -0.015 (-0.67%)
Spread: 0.12 (5.505%)
Open: 2.24
High: 2.24
Low: 2.24
Prev. Close: 2.255
IMM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

SABMiller exec buys a round

Tue, 24th Jan 2012 16:32

The Managing Director of SABMiller's African division bought a round of shares just one day before the drinks giant announced it has signed a definitive transaction agreement with Anadolu Group and Anadolu Efes.The agreement allows the firm to form a strategic alliance between the firm's divisions in Turkey, Russia, the Commonwealth of Independent States (CIS), Central Asia and the Middle East. The terms of the agreement, announced back in October, mean that SABMiller will now transfer its Russian and Ukranian beer divisions (valued at $1.9bn) to Anadolu Efes, the fifth-largest European brewer and the world's sixth-largest Coca-Cola bottler. In return, SABMiller will hold a 24% equity stake in Andolu Efes. Mark Bowman, 45, purchased 963 shares at 2,382.845p each. Just a few days ago the brewer reported that its financial performance for the final quarter of 2011 had been in line with expectations. However, the European and North American divisions were noticeably weak, with larger volumes in Europe falling 2% while in the US sales were down 3.3%. Top Director BuysImmupharma (IMM) Director name: Mr Ajay AgrawalAmount purchased: 62,169 @ 80.00p Value: £49,735Immupharma (IMM) Director name: Dr Franco Di MuzioAmount purchased: 60,950 @ 81.00p Value: £49,370Stobart Group Ltd. (STOB) Director name: Mr Jesper KjaedegaardAmount purchased: 22,000 @ 122.80p Value: £27,016Mission Marketing Group (TMMG) Director name: Mr Dylan BoggAmount purchased: 100,000 @ 15.12p Value: £15,120Mediterranean Oil & Gas (MOG) Director name: Mr Miles DonnellyAmount purchased: 225,000 @ 5.30p Value: £11,925NR
More News
7 Dec 2015 09:36

ImmuPharma Says US Sites Open For Lupuzor Phase III Trial Recruitment

Read more
4 Nov 2015 10:44

ImmuPharma's Lupuzor trial on track for 2017 completion

(ShareCast News) - ImmuPharma has reached a number of important milestones in the phase three clinical trial of Lupuzor. The AIM listed company provided an update to the market on Wednesday about the drug trial, its lead programme for the potential breakthrough compound for life threatening auto imm

Read more
4 Nov 2015 10:31

WINNERS & LOSERS SUMMARY: Housebuilders And Estate Agents Torn Down

Read more
4 Nov 2015 08:56

ImmuPharma Says Lupuzor Trials Set To Start In US This Year

Read more
30 Sep 2015 09:29

ImmuPharma Appoints Non-Executive Chairman As Loss Narrows

Read more
29 Jul 2015 09:16

ImmuPharma Says Chairman And Co-Founder Richard Warr Dies

Read more
27 Jul 2015 07:08

ImmuPharma Secures Financing To Continue Lupuzor Progress (ALLISS)

Read more
29 May 2015 07:28

LONDON MORNING BRIEFING: AB Foods Lifted To Buy From Sell By Goldman

Read more
29 May 2015 05:17

AGM, EGM Calendar - Week Ahead

Read more
28 May 2015 16:28

AGM, EGM Calendar - Week Ahead

Read more
6 May 2015 08:11

ImmuPharma Chairman Takes Leave To Deal With Health Issue

Read more
30 Apr 2015 09:37

Immupharma To Focus On Lupuzor, 2014 Loss Narrows On Trial End

Read more
11 Feb 2015 12:18

Immupharma Says Cancer Therapy Trial Meets Primary Objective

Read more
22 Jan 2015 12:00

UK MIDDAY BRIEFING: Royal Mail Up As It Meets Low Expectations

Read more
22 Jan 2015 11:19

UK WINNERS & LOSERS: Oxford Instruments Falls On Another Warning

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.